2026.02.09
SUBMISSION OF EU MDR CE MARK REGISTRATIO···
The board (the “Board”) of directors (the “Directors”) of the Company is pleased toannounce that the···
2025.12.26
SmartWave Medical Wins "Excellence Award···
In December 2025, the finals of the 2025 National Unicorn EnterpriseCompetitionconcluded. SmartWave ···
2025.12.13
ReachTact TAVR Assistance SystembyZhiche···
In December 2025, the ReachTact TAVR Assistance System, independentlydeveloped by Zhicheng Medical T···
2025.12.12
Peijia Medical Received NMPA Approval fo···
Peijia Medical (9996.HK), a leading Chinese domestic company inthehigh-growthtranscatheter valve the···
2025.12.08
Regurgitation Application of TaurusNXTNo···
In December 2025, Peijia Medical announced that the Companyreceivedaconfirmation letter from NMPA co···
2025.11.01
China-Developed Non-glutaraldehyde Cross···
On October 27, Professor Pan Wenzhi from Zhongshan Hospital, representing the teams of Academician G···
2025.10.31
Smart implant for Pressure-Guided Heart ···
At TCT 2025, Relief Cardiovascular, a company from the inQB8 incubator, won the Shark Tank innovatio···
2025.10.29
TaurusTrio Experience in Ultra-Large Ann···
Professor Song Guangyuan from Beijing Anzhen Hospital Capital Medical University, presented one-year···
2025.10.29
Professor Wang Yan Unveiled Groundbreaki···
At TCT 2025, Professor Wang Yan from Xiamen Cardiovascular Hospital was invited to deliver a keynote···
2025.10.28
3-Year Clinical Data of HighLife TSMVR: ···
Professor Wolfgang Rottbauer from Ulm University Heart Center presented 3-year results from the High···
2025.10.28
NTCVR Multicenter Study Confirmed Safety···
At TCT 2025, Professor Zhang Xiaochun from Zhongshan Hospital, representing the teams of Academician···
2025.09.12
FIRST IMPLANTATION IN THE FIM CLINICAL T···
This announcement is made by Peijia Medical Limited (the “Company”, together with itssubsidiaries, t···